While I find it surprising that Aguia feels the need to be...

While I find it surprising that Aguia feels the need to be investigating other markets rather than just relying on the domestic market, when it is already under supplied with Phosphate, it is not a poor strategy to a) have a back up plan should it make economic sense to transport it to Australia or other like countries and b) more importantly having the product validated in another respected jurisdiction such as Australia should add to its value and credibility. So neither of these are negative events. The odd sell down of the stock price is again the anomaly against at worst neutral news, but could be very positive when the test result come out. Management would not be doing this if they had any doubts that this product will perform well in Australian conditions.